At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DVA DaVita HealthCare Partners
Trading 05-18 13:09:49 EDT
200.15
+0.41
+0.21%
High202.00Low198.76Vol285.86K
Open199.40D1 Closing199.74Amplitude1.62%
Mkt Cap12.85BTradable Cap6.53BTotal Shares64.20M
T/O57.21MT/O Rate0.88%Tradable Shares32.63M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

DaVita Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  05-16 05:13
DaVita Inc. Stock Outperforms Competitors On Strong Trading Day
Companies Have a New AI Problem: Too Many Agents -- WSJ
Dow Jones  ·  05-15
Companies Have a New AI Problem: Too Many Agents -- WSJ
DaVita Inc. Stock Underperforms Wednesday When Compared To Competitors
Dow Jones  ·  05-14
DaVita Inc. Stock Underperforms Wednesday When Compared To Competitors
DaVita CFO Joel Ackerman disposes 51,471 shares worth $9.89 million
Reuters  ·  05-12
DaVita CFO Joel Ackerman disposes 51,471 shares worth $9.89 million
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and DaVita (DVA)
TIPRANKS  ·  05-11
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and DaVita (DVA)
Weekly Winners | Datadog, Akamai Rocket 42% Each; Memory Stocks Continue to Surge with Micron Up 38%, Sandisk Up 32%; SMCI Rises 30%; AMD Gains 26%; Intel Jumps 25%
Tiger Newspress  ·  05-10
Weekly Winners | Datadog, Akamai Rocket 42% Each; Memory Stocks Continue to Surge with Micron Up 38%, Sandisk Up 32%; SMCI Rises 30%; AMD Gains 26%; Intel Jumps 25%
DaVita Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
Dow Jones  ·  05-09
DaVita Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
DaVita Chief Compliance Officer James Hearty sells 2,184 shares worth $381,712.08
Reuters  ·  05-09
DaVita Chief Compliance Officer James Hearty sells 2,184 shares worth $381,712.08
Truist Securities Adjusts DaVita Price Target to $205 From $158, Maintains Hold Rating
MT Newswires Live  ·  05-08
Truist Securities Adjusts DaVita Price Target to $205 From $158, Maintains Hold Rating
DaVita price target raised to $205 from $158 at Truist
TIPRANKS  ·  05-08
DaVita price target raised to $205 from $158 at Truist
DaVita Is Maintained at Buy by UBS
Dow Jones  ·  05-08
DaVita Is Maintained at Buy by UBS
DaVita Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  05-08
DaVita Inc. Stock Outperforms Competitors On Strong Trading Day
Barclays Adjusts Price Target on DaVita to $194 From $158
MT Newswires Live  ·  05-07
Barclays Adjusts Price Target on DaVita to $194 From $158
Early notable gainers among liquid option names on May 6th
TIPRANKS  ·  05-07
Early notable gainers among liquid option names on May 6th
DaVita rises 19.6%
TIPRANKS  ·  05-07
DaVita rises 19.6%
DaVita CFO, investor relations chief join BofA Securities Health Care Conference fireside chat
Reuters  ·  05-07
DaVita CFO, investor relations chief join BofA Securities Health Care Conference fireside chat
DaVita Inc. Stock Climbs 23.5%, Outperforms Peers
Dow Jones  ·  05-07
DaVita Inc. Stock Climbs 23.5%, Outperforms Peers
Stock Track | DaVita HealthCare Partners Soars 22.55% Intraday on Strong Q1 Earnings Beat and Raised Full-Year Guidance
Stock Track  ·  05-07
Stock Track | DaVita HealthCare Partners Soars 22.55% Intraday on Strong Q1 Earnings Beat and Raised Full-Year Guidance
BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
Reuters  ·  05-07
BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
DaVita Shares Touch Record High, Last up 20.3%
THOMSON REUTERS  ·  05-06
DaVita Shares Touch Record High, Last up 20.3%

Introduction

Company Name.
DaVita HealthCare Partners
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Issue price:
--